Non-invasive metabolomic analysis using a commercial NIR instrument for embryo selection
- PMID: 24082655
- PMCID: PMC3778603
- DOI: 10.4103/0974-1208.117174
Non-invasive metabolomic analysis using a commercial NIR instrument for embryo selection
Abstract
Context: Metabolomics was introduced in human in vitro fertilization (IVF) for noninvasive identification of viable embryos with the highest developmental competence.
Aims: To determine whether embryo selection using a commercial version of metabolomic analysis leads to increased implantation rates (IRs) with fetal cardiac activity (FCA) compared with morphology evaluation alone.
Setting and design: Randomized controlled trial from April to December 2010 at a private IVF unit. The study was terminated prematurely due to the market withdrawal of the instrument.
Materials and methods: IVF patients ≥18 and ≤43 years with ≥4 × 2PN were randomly allocated to metabolomic analysis combined with embryo morphology (ViaMetrics-E; metabolomics + morphology group) or embryo morphology alone (morphology group). Cycles with frozen embryos, oocyte donations, or testicular biopsy were excluded.
Statistical analysis: Categorical and continuous data were analyzed for statistical significance using 2-tailed Fisher's exact test and t-test, respectively. Statistical significance was accepted when P > 0.05.
Results: A total of 125 patients were included in the study; 39 patients were allocated to metabolomics + morphology group and 86 patients to morphology group. Patients were stratified according to the day of embryo transfer (Days 2, 3, or 5). IRs with FCA were similar for Days 2 and 3 transfers in both groups. For Day 5 transfers, IRs with FCA were significantly higher in the metabolomics + morphology group (46.8% vs. 28.9%; P = 0.041; 95% confidence intervalp [CI]: 1.09-34.18). Pregnancy and live births rates were similar for Days 2, 3, and 5 in both groups. The study was terminated early following the voluntary market withdrawal of ViaMetrics-E in December 2010.
Conclusions: Metabolomic analysis using the commercial near-infrared (NIR) instrument does not appear to have a beneficial effect on pregnancy and live births, with improvement in IR with FCA for Day 5 transfers. However, no solid conclusions can be reached due to the lack of adequate study power.ClinicalTrials.gov Identifier: NCT01490515.
Keywords: Embryo selection; implantation rates; metabolomics; near-infrared; noninvasive.
Conflict of interest statement
References
-
- Scott L, Finn A, O’Leary T, McLellan S, Hill J. Morphologic parameters of early cleavage-stage embryos that correlate with fetal development and delivery: Prospective and applied data for increased pregnancy rates. Hum Reprod. 2007;22:230–40. - PubMed
-
- Guerif F, Le Gouge A, Giraudeau B, Poindron J, Bidault R, Gasnier O, et al. Limited value of morphological assessment at days 1 and 2 to predict blastocyst development potential: A prospective study based on 4042 embryos. Hum Reprod. 2007;22:1973–81. - PubMed
-
- Milki AA, Hinckley MD, Gebhardt J, Dasig D, Westphal LM, Behr B. Accuracy of day 3 criteria for selecting the best embryos. Fertil Steril. 2002;77:1191–5. - PubMed
-
- Neuber E, Mahutte NG, Arici A, Sakkas D. Sequential embryo assessment outperforms investigator-driven morphological assessment at selecting a good quality blastocyst. Fertil Steril. 2006;85:794–6. - PubMed
-
- Katz-Jaffe MG, Gardner DK. Symposium: Innovative techniques in human embryo viability assessment. Can proteomics help to shape the future of human assisted conception? Reprod Biomed Online. 2008;17:497–501. - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous